Status:
COMPLETED
Clinical Effects of a Nucleotides-Supplemented Infant Formula
Lead Sponsor:
Soroka University Medical Center
Collaborating Sponsors:
Materna Laboratories
Conditions:
Nutritional Requirements
Eligibility:
All Genders
1-30 years
Phase:
NA
Brief Summary
The study hypothesis is that different concentrations of nucleotides' supplementation of an infant formula might affect differently growth and/or other clinical parameters in neonates.
Detailed Description
Three groups of 50 newborn infants each, will be fed for 30 days an infant formula supplemented with either 4.9 mg/100 kcal or 10.6 mg/100 kcal of nucleotides or with no supplementation. Newborns will...
Eligibility Criteria
Inclusion
- Healthy newborns aged 0-30 days.
Exclusion
- Prematurity
- Chronic illness
- Failure to thrive
- Milk allergy
Key Trial Info
Start Date :
March 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2007
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT00292812
Start Date
March 1 2006
End Date
October 1 2007
Last Update
October 23 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Soroka Medical Center
Beersheba, Israel, 84101